Concepedia

Sophia Stock

SS

Statistics

Publications

14

Citations

817

H-Index

13

Active since

2018

Affiliations

Deutsches Konsortium für Translationale Krebsforschung(Current)

German Cancer Research Center

Heidelberg University

Helmholtz Zentrum München

University Hospital Heidelberg

Sophia Stock is an author at Deutsches Konsortium für Translationale Krebsforschung specializing in immunotherapy, cancer immunology, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2018–2025

14

Publications

14

PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells

Sebastian Lacher, Janina Dörr, Gustavo P. de Almeida et al. · Nature · 2024 · 172 citations · Full text

, , +9

Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia

Adrian Gottschlich, Moritz Thomas, Ruth Grünmeier et al. · Nature Biotechnology · 2023 · 111 citations · Full text

, , +16

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Jean‐Marc Hoffmann, Maria‐Luisa Schubert, Lei Wang et al. · Frontiers in Immunology · 2018 · 99 citations · Full text

, , +17

Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients

Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert et al. · International Journal of Cancer · 2019 · 80 citations · Full text

, , +17

Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients

Fuli Fan, Sophia Stock, Lei Wang et al. · International Journal of Cancer · 2020 · 73 citations · Full text

, , +17

1–5 of 14